Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Lymphedema × Tacrolimus × Clear all

Phase

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Myelodysplastic Syndromes 1 Lymphoma, Follicular 1 Lymphedema 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Leukemia, Myeloid, Accelerated Phase 1 Leukemia 1 Graft vs Host Disease 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06306274 2024-12-02

Topical Tacrolimus for Breast Cancer-related Lymphedema

Odense University Hospital

Phase 2/3 Enrolling by invitation

Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡